Related references
Note: Only part of the references are listed.Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature
Megan O. Jacus et al.
CLINICAL PHARMACOKINETICS (2016)
Clinical trial of blood-brain barrier disruption by pulsed ultrasound
Alexandre Carpentier et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort
Johan Pallud et al.
NEURO-ONCOLOGY (2015)
The role of Gliadel wafers in the treatment of newly diagnosed GBM: a meta-analysis
Wei-kang Xing et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent brain parenchyma
Stephan Ulmer et al.
NEURO-ONCOLOGY (2012)
Breaching the barrier
Alan Dove
NATURE BIOTECHNOLOGY (2008)
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
SS Gill et al.
NATURE MEDICINE (2003)
Pharmacokinetics of the carmustine implant
AB Fleming et al.
CLINICAL PHARMACOKINETICS (2002)
Share Paper
